UnitedHealth Group Incorporated (NYSE:UNH) previous close was $364.37 while the outstanding shares total 949.00M. The firm has a beta of 0.77, a 12-month trailing P/E ratio of 22.81, and a growth ratio of 1.84. UNH’s shares traded higher over the last trading session, gaining 0.35% on 04/07/21. The shares fell to a low of $360.55 before closing at $365.64. Intraday shares traded counted 2.16 million, which was 36.23% higher than its 30-day average trading volume of 3.38M. The stock’s Relative Strength Index (RSI) is 56.55, with weekly volatility at 1.62% and ATR at 7.08. The UNH stock’s 52-week price range has touched low of $246.26 and a $380.50 high.
Investors have identified the Healthcare Plans company UnitedHealth Group Incorporated as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $350.36 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
UnitedHealth Group Incorporated (UNH) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 53.72 billion total, with 72.42 billion as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 21.16 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on UNH sounds very interesting.
Is the stock of UNH attractive?
In related news, Director, BURKE RICHARD T sold 6,000 shares of the company’s stock in a transaction that recorded on Mar 16. The sale was performed at an average price of 354.90, for a total value of 2,129,419. As the sale deal closes, the Director, BURKE RICHARD T now sold 4,000 shares of the company’s stock, valued at 1,413,300. Also, Chief Accounting Officer, ROOS THOMAS E sold 423 shares of the company’s stock in a deal that was recorded on Mar 01. The shares were price at an average price of 334.36 per share, with a total market value of 141,434. Following this completion of acquisition, the Director, BURKE RICHARD T now holds 5,000 shares of the company’s stock, valued at 1,637,995. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.30%.
18 out of 25 analysts covering the stock have rated it a Buy, while 6 have maintained a Hold recommendation on UnitedHealth Group Incorporated. 0 analysts has assigned a Sell rating on the UNH stock. The 12-month mean consensus price target for the company’s shares has been set at $396.63.